Antihistamine OTC Switch Moves To Legal Arena After Committee Votes
Executive Summary
The potential OTC switch of the antihistamines Claritin, Allegra and Zyrtec will move into the legal arena following a review by FDA's Nonprescription and Pulmonary-Allergy Drugs Advisory Committees May 11.
You may also be interested in...
WellPoint Swears Off Switch Petitions; Antihistamine Campaign Had PR Costs
The adverse publicity surrounding WellPoint's petition to force an OTC switch of nonsedating antihistamines has convinced the insurer not to pursue similar efforts in the future, WellPoint Health Networks Chief Pharmacy Officer Robert Seidman told a recent IIR conference in Philadelphia
WellPoint Swears Off Switch Petitions; Antihistamine Campaign Had PR Costs
The adverse publicity surrounding WellPoint's petition to force an OTC switch of nonsedating antihistamines has convinced the insurer not to pursue similar efforts in the future, WellPoint Health Networks Chief Pharmacy Officer Robert Seidman told a recent IIR conference in Philadelphia
Zyrtec OTC Switch: Pfizer Says Rx Status Necessary For “Best Use” Of Drug
A forced OTC switch of Zyrtec would deprive consumers of the "health information component" doctors provide, which is needed for optimal care, Pfizer CEO Henry McKinnell said during the firm's April 24 annual meeting in Ann Arbor, Mich